Free shipping on all orders over $ 500

AST2818 mesylate

Cat. No. M9400
AST2818 mesylate Structure
Synonym:

Alflutinib mesylate

Size Price Availability Quantity
10mg USD 520 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

AST2818 mesylate is a third generation EGFR inhibitor that targets both EGFR activating mutations and T790M thus leading to tumor growth inhibition.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 664.7
Formula C29H35F3N8O5S
CAS Number 2130958-55-1
Purity >99%
Solubility DMSO ≥ 3 mg/mL (Need ultrasonic)
Storage at -20°C
References

Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Pat-ients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial.
Y Shi, et al. J Thorac Oncol. 2017 Nov;12(11): S2138.

Related EGFR/HER2 Products
Mobocertinib

Mobocertinib (TAK-788) is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions.

TAS6417

TAS6417 is a novel EGFR inhibitor targeting exon 20 insertion mutations, with IC50 values range from 1.1-8.0 nM.

ABM-3627

ABM-3627, also known as Mutant EGFR inhibitor, is a selective and potent Mutated EGFR inhibitor.

Pertuzumab

Pertuzumab, a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors, impairs the ability of HER2 to bind to other members of the HER family, MW: 148 KD.

Trastuzumab

Trastuzumab is a humanized, recombinant monoclonal antibody that binds to the extracellular domain of HER2, MW:145.53 KD.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: AST2818 mesylate, Alflutinib mesylate supplier, EGFR/HER2, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.